Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 95
of 5Next
1:

The relationship between cancer and rheumatoid arthritis: still a large research agenda.

Love T, Solomon DH.

Arthritis Res Ther. 2008;10(3):109. Epub 2008 May 14.

PMID: 18495048 [PubMed - in process]

2:

Are patients with RA at increased risk of malignancy?

Hyrich KL.

Nat Clin Pract Rheumatol. 2008 Dec;4(12):632-3. Epub 2008 Oct 14.

PMID: 18852717 [PubMed - in process]

3:

Risk of malignancy among patients with rheumatic conditions.

Thomas E, Brewster DH, Black RJ, Macfarlane GJ.

Int J Cancer. 2000 Nov 1;88(3):497-502.

PMID: 11054684 [PubMed - indexed for MEDLINE]

4:

Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.

Wolfe F, Michaud K.

Arthritis Rheum. 2004 Jun;50(6):1740-51.

PMID: 15188349 [PubMed - indexed for MEDLINE]

6:

Rheumatoid arthritis and the risk of malignancy.

Cibere J, Sibley J, Haga M.

Arthritis Rheum. 1997 Sep;40(9):1580-6.

PMID: 9324011 [PubMed - indexed for MEDLINE]

7:

Rheumatoid arthritis and malignant lymphomas.

Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L.

Curr Opin Rheumatol. 2004 May;16(3):254-61. Review.

PMID: 15103253 [PubMed - indexed for MEDLINE]

8:

Incidence of cancer among patients with rheumatoid arthritis.

Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R, Fraumeni JF Jr.

J Natl Cancer Inst. 1993 Feb 17;85(4):307-11.

PMID: 8426374 [PubMed - indexed for MEDLINE]

9:

Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.

Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, Kim TH, Jun JB, Yoo DH, Lee JT, Bae SC.

J Rheumatol. 2007 Apr;34(4):706-11. Epub 2007 Feb 15.

PMID: 17309133 [PubMed - indexed for MEDLINE]

10:

Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.

Chakravarty EF, Michaud K, Wolfe F.

J Rheumatol. 2005 Nov;32(11):2130-5.

PMID: 16265690 [PubMed - indexed for MEDLINE]

11:

Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis.

Jorgensen C, Picot MC, Bologna C, Sany J.

Ann Rheum Dis. 1996 Feb;55(2):94-8.

PMID: 8712873 [PubMed - indexed for MEDLINE]

12:

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.

Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, Sundström C, Bertilsson L, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Klareskog L, Feltelius N.

Ann Rheum Dis. 2005 Oct;64(10):1414-20. Epub 2005 Apr 20.

PMID: 15843454 [PubMed - indexed for MEDLINE]

13:

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis.

Setoguchi S, Solomon DH, Weinblatt ME, Katz JN, Avorn J, Glynn RJ, Cook EF, Carney G, Schneeweiss S.

Arthritis Rheum. 2006 Sep;54(9):2757-64. Erratum in: Arthritis Rheum. 2006 Oct;54(10):3134.

PMID: 16947774 [PubMed - indexed for MEDLINE]

14:

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.

Jacobsson LT, Turesson C, Gülfe A, Kapetanovic MC, Petersson IF, Saxne T, Geborek P.

J Rheumatol. 2005 Jul;32(7):1213-8.

PMID: 15996054 [PubMed - indexed for MEDLINE]

15:

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V.

JAMA. 2006 May 17;295(19):2275-85. Review. Erratum in: JAMA. 2006 Jun 7;295(21):2482.

PMID: 16705109 [PubMed - indexed for MEDLINE]

16:

The incidence of cancer associated with the treatment of rheumatoid arthritis.

Beauparlant P, Papp K, Haraoui B.

Semin Arthritis Rheum. 1999 Dec;29(3):148-58.

PMID: 10622679 [PubMed - indexed for MEDLINE]

17:

Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis.

Schneeweiss S, Setoguchi S, Weinblatt ME, Katz JN, Avorn J, Sax PE, Levin R, Solomon DH.

Arthritis Rheum. 2007 Jun;56(6):1754-64.

PMID: 17530704 [PubMed - indexed for MEDLINE]

18:

Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study.

Wolfe F, Michaud K.

Arthritis Rheum. 2007 Sep;56(9):2886-95.

PMID: 17729297 [PubMed - indexed for MEDLINE]

19:

Malignancy and autoimmunity.

Bernatsky S, Ramsey-Goldman R, Clarke A.

Curr Opin Rheumatol. 2006 Mar;18(2):129-34. Review.

PMID: 16462517 [PubMed - indexed for MEDLINE]

20:

No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.

van den Borne BE, Landewé RB, Houkes I, Schild F, van der Heyden PC, Hazes JM, Vandenbroucke JP, Zwinderman AH, Goei The HS, Breedveld FC, Bernelot Moens HJ, Kluin PM, Dijkmans BA.

Arthritis Rheum. 1998 Nov;41(11):1930-7.

PMID: 9811046 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 95
of 5Next